Psittacosis future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{{EH}}{{Psittacosis}}{{CMG}} ==Overview== ==References== {{reflist|2}} {{Bacterial diseases}} da:Psittacosis de:Ornithose fr:ornithose hr:Psitakoza [[it:Ps...") |
No edit summary |
||
| Line 1: | Line 1: | ||
{{ | __NOTOC__ | ||
{{Psittacosis}} | |||
{{CMG}}; {{AE}} {{ADI}} | |||
==Overview== | ==Overview== | ||
==Future == | |||
* Future challenges lay in the rigorous reporting of infections in both poultry and poultry workers and in the development of an avian and human vaccine.<ref name="pmid22302240">{{cite journal |author=Deschuyffeleer TP, Tyberghien LF, Dickx VL, ''et al.'' |title=Risk assessment and management of Chlamydia psittaci in poultry processing plants |journal=Ann Occup Hyg |volume=56 |issue=3 |pages=340–9 |year=2012 |month=April |pmid=22302240 |doi=10.1093/annhyg/mer102 |url=}}</ref> | |||
* Use of ovotransferrin as anitmicrobial in poultry to reduce dissemination of bacteria into air. <ref name="pmid21885218">{{cite journal |author=Van Droogenbroeck C, Dossche L, Wauman T, ''et al.'' |title=Use of ovotransferrin as an antimicrobial in turkeys naturally infected with Chlamydia psittaci, avian metapneumovirus and Ornithobacterium rhinotracheale |journal=Vet. Microbiol. |volume=153 |issue=3-4 |pages=257–63 |year=2011 |month=December |pmid=21885218 |doi=10.1016/j.vetmic.2011.05.016 |url=}}</ref> | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 19:21, 7 August 2012
|
Psittacosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Psittacosis future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Psittacosis future or investigational therapies |
|
Risk calculators and risk factors for Psittacosis future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]
Overview
Future
- Future challenges lay in the rigorous reporting of infections in both poultry and poultry workers and in the development of an avian and human vaccine.[1]
- Use of ovotransferrin as anitmicrobial in poultry to reduce dissemination of bacteria into air. [2]
References
- ↑ Deschuyffeleer TP, Tyberghien LF, Dickx VL; et al. (2012). "Risk assessment and management of Chlamydia psittaci in poultry processing plants". Ann Occup Hyg. 56 (3): 340–9. doi:10.1093/annhyg/mer102. PMID 22302240. Unknown parameter
|month=ignored (help) - ↑ Van Droogenbroeck C, Dossche L, Wauman T; et al. (2011). "Use of ovotransferrin as an antimicrobial in turkeys naturally infected with Chlamydia psittaci, avian metapneumovirus and Ornithobacterium rhinotracheale". Vet. Microbiol. 153 (3–4): 257–63. doi:10.1016/j.vetmic.2011.05.016. PMID 21885218. Unknown parameter
|month=ignored (help)